Is telemedicine as effective as in-person medical care?

When is telemedicine just as good as in-person care?

For mental health care, the evidence is strong that telemedicine is a viable alternative. A 2022 meta-analysis of 12 randomized trials found no significant difference in symptom severity between telehealth and face-to-face therapy for conditions like addiction, eating disorders, and childhood mental health problems, with a standardized mean difference of just 0.05 (essentially zero) [3]. For depression specifically, a separate meta-analysis of 9 trials found no difference in depression severity at the end of treatment, with a standardized mean difference of -0.04 [5]. For PTSD, another meta-analysis of 13 trials found no difference in PTSD severity at 6 months (standardized mean difference -0.11) [6]. These results mean that for most people, getting therapy via video or phone is as effective as sitting in a therapist's office.

For chronic disease management, telemedicine also holds up well. A large 2024 trial of 1,250 patients with advanced lung cancer found that early palliative care delivered via video was equivalent to in-person care for quality of life, with scores of 99.7 vs. 97.7 on a 136-point scale (a difference of only 2 points, well within the predefined equivalence margin) [1]. For diabetes, a 2022 study of over 18,000 patients found that those with two or more telemedicine visits actually had slightly lower odds of uncontrolled diabetes (HbA1c ≥9%) compared to those with only in-person visits (odds ratio 0.88) [12]. Another study of 166 community health centers found that higher continuity of care—which was facilitated by telehealth—was linked to better blood pressure and blood sugar control [11].

Even for some surgical triage, telemedicine can be effective. A 2024 study of patients undergoing septoplasty (nasal surgery) found that those initially evaluated via telemedicine had a shorter time to surgery (208 vs. 434 days) and no excess in unnecessary lab tests or imaging, despite having slightly more preoperative visits [13].

Where does telemedicine come up short?

The biggest limitation is the lack of a physical exam. In a 2024 survey of primary care providers, 15% of telemedicine visits were rated as less successful than in-person visits, and two-thirds of those failures were due to the inability to perform a physical exam [14]. Conditions involving the respiratory system, gastrointestinal issues, and musculoskeletal problems were particularly likely to be less successful via telemedicine [14]. This aligns with a large 2023 study of 1.6 million primary care visits, which found that telemedicine visits (especially phone visits) led to fewer medication prescriptions and less lab/imaging ordering compared to in-person visits [10].

Telemedicine also tends to generate more follow-up care. The same 2023 study found that after a telemedicine visit, 6.2% of video visits and 7.6% of phone visits required a return in-person visit within 7 days, compared to just 1.3% after an in-person visit [10]. Similarly, a 2024 pediatric study found that telemedicine visits were followed by more in-person follow-up visits (14.4% for video vs. 4.3% for in-person) and slightly more emergency department visits (2.04% vs. 1.75%) within a week [2]. This suggests that telemedicine is good for initial triage and simple issues, but some problems ultimately need hands-on care.

For complex conditions, telemedicine may lead to less aggressive treatment. A 2025 study of adults with complex type 2 diabetes found that those using telemedicine were less likely to receive newer, risk-reducing medications like GLP-1 receptor agonists or SGLT2 inhibitors (odds ratio 0.87) compared to those seen in person [8]. They also had fewer endocrinology, primary care, and nutrition visits overall [8]. This raises a concern that telemedicine might inadvertently lead to less intensive management for patients who need it most.

Does telemedicine help people who have trouble getting care?

Yes, telemedicine appears to be especially beneficial for rural and underserved populations, often outperforming in-person care in these groups. For hepatitis C treatment, a 2026 meta-analysis of 15 studies found that while telemedicine was comparable overall, it was significantly better than in-person care for achieving a cure (sustained virologic response) in rural settings, with an odds ratio of 4.19 [7]. The same study noted that telemedicine improved treatment linkage and cure rates among people who use drugs and incarcerated individuals [7].

For opioid use disorder, a 2024 study found that telemedicine was associated with better medication adherence for rural patients. At 180 days, rural patients using telemedicine had an 8.5% higher medication possession ratio and 9.4% fewer gaps in treatment compared to in-person visits [9]. This is critical because rural areas often have limited access to addiction specialists.

A 2022 study of over 500,000 patients in a large health system found that patients who used telemedicine actually had better performance on many preventive care measures, including cancer screenings (e.g., 16.9% higher for breast cancer screening), vaccinations (9.8% higher for flu shots), and blood pressure control (3.6% higher) compared to those with only in-person visits [4]. This suggests that telemedicine can help keep people engaged in preventive care, especially when travel or time is a barrier.

Sources used in this answer

Related research questions